Why the Anti-Abortion Movement Is Turning on Donald Trump
Anti-abortion leaders, led by Marjorie Dannenfelser of Susan B. Anthony Pro-Life America, are distancing themselves from President Donald Trump. Frustrated by his refusal to support a national abortion ban and the FDA’s approval of generic mifepristone, these groups are threatening to divert $160 million in funding toward the 2028 primary.
For years, the alliance between the “pro-life” lobby and Donald Trump was a cornerstone of the modern American right. It was a marriage of convenience that yielded the most significant judicial shift in a generation: the overturning of Roe v. Wade. But as of May 2026, that marriage is facing a bitter separation.
The friction isn’t about a lack of passion from the activists; it is about a perceived lack of resolve from the Oval Office. To the leadership of the anti-abortion movement, the current administration’s “states-only” strategy is not a pragmatic political compromise—it is an existential failure.
“If the Republican Party fully follows this administration’s states-only strategy and abandons its commitments to pro-life action at the national level, then the movement as we know it is finished,” Marjorie Dannenfelser told members at the Susan B. Anthony (SBA) Pro-Life America April gala.
The stakes are no longer theoretical. Dannenfelser claims there are now more abortions occurring in the United States than there were on the day Roe Wade was overturned. This surge has turned a victory lap into a panic.
The Mifepristone Flashpoint and the FDA Rift
The primary catalyst for this current revolt is the accessibility of abortion pills. The anti-abortion movement has shifted its focus toward mifepristone, the first drug used in a medication abortion, because telehealth and mail-order services have effectively bypassed many state-level bans.
The movement is particularly incensed by the actions of FDA administrator Marty Makary. By approving a generic version of mifepristone and maintaining Biden-era regulations that allow women to order the drug via telehealth without an in-person physician visit, the administration has essentially neutralized many of the hard-won state restrictions.
The reaction from SBA Pro-Life America was swift and severe. Last December, the group called for Makary to be fired. When the administration didn’t budge, the frustration migrated upward.
“The president is the problem.”
That direct assessment from Dannenfelser to the Wall Street Journal signals a total collapse of the trust that once bound the social conservative wing to the Trump presidency. For those navigating the fallout of these shifting regulations, the legal landscape has become a minefield. Many healthcare providers are now seeking guidance from [Healthcare Compliance Consultants] to ensure their telehealth protocols don’t accidentally trigger federal or state criminal penalties.
A $160 Million Warning Shot
The anti-abortion lobby does not just operate on principle; it operates on power. The Susan B. Anthony List is widely regarded as the most politically connected entity in the pro-life space. While groups like the March for Life and the Family Research Council carry significant moral weight, SBA is known as the “knife fighter” of the lobby.
To prove they are serious, SBA announced a massive financial mobilization. They are planning to spend $160 million across the upcoming midterms and the 2028 Republican presidential primary.
This isn’t just about winning seats; it’s about vetting the future of the GOP. The message is clear: any candidate seeking their support must commit to federal action—specifically a national abortion ban—rather than deferring to the states.
This creates a volatile dynamic within the Republican Party. While the administration believes that avoiding the abortion issue allows them to pick up more seats in the midterms, the pro-life lobby believes that running away from the issue is a betrayal of the party’s core identity.
The Transactional Divide: Principle vs. Politics
The rift highlights a fundamental difference in operating philosophy. The pro-life movement is driven by a singular, non-negotiable principle. Donald Trump, conversely, is widely viewed as a transactional leader.
In 2016 and 2020, Trump positioned himself as a social conservative champion, famously using the debate stage to attack “partial birth abortion” and painting his opponents as extremists. This strategy successfully brought social conservatives into his fold, regardless of his personal history.
However, once the Supreme Court delivered the Dobbs decision, Trump’s calculus shifted. According to reporting from the Wall Street Journal, when Dannenfelser pressed for federal action, the response from the president was: “No. This issue is killing us.”
From the White House perspective, the “work is done.” From the activist perspective, the work has only just begun. This disconnect has left a vacuum of leadership that is now being filled by internal party conflict.
The State-Level Patchwork and Local Chaos
The refusal to enact a federal ban has created a chaotic “patchwork” of legality across the U.S. In states like Texas and Mississippi, abortion is almost entirely prohibited, while in others, it remains fully accessible. This geographical disparity has turned the U.S. Into a series of “abortion deserts” and “safe havens.”
This fragmentation has profound implications for local infrastructure and the legal system. Municipal courts in restrictive states are seeing an influx of cases related to medication abortion, while clinics in “haven” states are overwhelmed by out-of-state patients.
Legal experts suggest that without federal clarity, the judiciary will remain the primary battleground. "The absence of a federal standard transforms every state border into a legal precipice, where a medical act that is legal in one zip code becomes a felony in the next," notes a senior fellow at a leading constitutional law center.
As the legal volatility increases, individuals and organizations are increasingly relying on [Constitutional Law Firms] to protect themselves from the shifting interpretations of state-level “trigger laws” and federal FDA guidelines.
The current struggle is more than a policy dispute; it is a fight for the soul of the American right. The pro-life lobby is attempting to ensure that the definition of conservatism in 2028 remains tethered to robust limitations on abortion, regardless of who holds the presidency.
Whether this $160 million threat will force the administration’s hand or simply accelerate a permanent schism remains to be seen. For now, the movement is no longer looking to the White House for leadership—they are preparing to buy it. As the political landscape continues to shift, those affected by these legal contradictions should consult verified [Civic Advocacy Groups] to navigate their rights and responsibilities in an era of unprecedented judicial instability.